Form 4 for CRVS Corvus Pharmaceuticals, Inc.

Accepted 2022-09-20 00:00:00 ET · period of report 2022-09-20 · accession 0001567619-22-017639 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2022-09-20	2022-09-20	CRVS	MILLER RICHARD A MD	Pres, CEO, Dir	P - Purchase	$0.8138	+20.0K	1.36M	+1%	+$16.3K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-09-20	P	A	2,700	$0.82	1,364,405	I By Trust	—	—	(F1) These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
2	Common	Common Stock	2022-09-20	P	A	5,000	$0.82	1,369,405	I By Trust	—	—	(F1) These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
3	Common	Common Stock	2022-09-20	P	A	12,300	$0.81	1,361,705	I By Trust	—	—	(F1) These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.